Evidence map›Paper›PMID 32164551›Full record

ArticleBMC infectious diseases2020

Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection.

Chenyan Yuan, Huixia Lu, Congshan Yang, Wei Gao, Hailiang Wang, Guoqiu Wu

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Clonal spread of Mycobacterium monacense strains among patients with extrapulmonary mycobacteriosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Coinfection ofHeliyon · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenyan YuanDepartment of Clinical Laboratory, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Huixia LuDepartment of Clinical Laboratory, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Congshan YangDepartment of Critical Care Medicine, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Wei GaoDepartment of Clinical Laboratory, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Hailiang WangDepartment of Clinical Laboratory, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Guoqiu WuDepartment of Clinical Laboratory, Affiliated Zhongda Hospital, Southeast University, Nanjing, China. nationball@163.com.

Funding

National Natural Science Foundation of China 81501525
6 · The paper itself

Abstract

backgroundThe poorly known mycobacterial species Mycobacterium monacense is a rapidly growing non-tuberculous mycobacterium that was first described in 2006 (Reischl et al., Int J Syst Evol Microbiol 56:2575-8, 2006); it has been reported that its isolation is usually associated with skin and lung infections, especially in immunosuppressed patients (Hogardt et al., Jpn J Infect Dis 61:77-8, 2008; Taieb et al., J Hand Surg Am 33:94-6, 2008; Therese et al., Lung India 28:124-6, 2011; Shojaei et al., Ann Lab Med 32:87-90, 2012; Romero et al., New Microbes New Infect 10:112-5, 2016 ). The clinical significance of Mycobacterium monacense is not yet fully understood. Here, we report the first isolation of Mycobacterium monacense from the blood culture of a patient in China with severe pneumonia. CASE PRESENTATION: On June 26, 2018, a 38-year-old man was admitted to the intensive care unit with breathing difficulty. One day prior, he was discovered with his face immersed in a small pond (non-chlorinated water) and with limb convulsions. He had undergone craniocerebral surgery after trauma 5 years earlier, which left him with epilepsy as a sequela. Bilateral diffuse ground-glass opacity was found in the lungs on chest X ray and chest CT image at admission. The result of the HIV serology test of the patient was negative. The patient was diagnosed with severe pneumonia. Drug-susceptible Klebsiella pneumoniae and Candida glabrata were isolated in the BALF, and yellow-pigmented colonies were isolated from blood cultures of the patient. The strain isolated from blood was identified by 16S rDNA sequencing as Mycobacteria monacense, which is a rapidly growing mycobacterium (RGM). The patient was treated with a combination of cefoperazone sulbactam, linezolid and voriconazole for 10 days, and the symptoms improved. During the one-year follow-up time, the patient did not relapse.

conclusionsWe report the first case of M. monacense isolated from blood cultures in a patient with severe pneumonia, which provided evidence that the environmental microorganism possessed pathogenic characteristics.

Indexed as

AdultBlood CultureCefoperazoneChinaDNA, RibosomalHumansLinezolidMaleMycobacteriumMycobacterium Infections, NontuberculousPneumonia, BacterialSulbactamVoriconazoleCefoperazoneDNA, RibosomalLinezolidSulbactamVoriconazoleBlood streamInfectionMycobacterium monacenseSevere pneumonia

Identifiers

PMID32164551
PMCPMC7068891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.